ELLFF: The Evaluation of the Lower Limb Function After Femur Fracture's Operation Treatment

Sponsor
Jagiellonian University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04062604
Collaborator
(none)
350
1
36
9.7

Study Details

Study Description

Brief Summary

The goal of this study is the evaluation of lower limb function and the quaility of life of the patients after femur fracture operation treatment. LLTQ (Lower-Limb Tasks Questionnaire), LEFS (Lower Extremity Funcional Scale), LLFI-10 (Lower Limb Functional Index - 10) and LLFI (Lower Limb Functional Index) will be used for all the patients.

Condition or Disease Intervention/Treatment Phase
  • Other: surgery

Detailed Description

All four questionnaires (LLTQ, LEFS LLFI-10 and LLFI) will be translated and adopted to the Polish conditions. The detailed medical/ epidemiological history will be collected in each patient. The fracture will be assessed based on the x-ray examination and will be qualified according to AO classification. NRS (Numerical Rating Scale) will be used to assess the pain intensity. SF36, QoL, CSQ, COPE and HADS questionnaire will be used to evaluate patient's the quality of life (subjective assessment). First assessment will be done before operation and then after 3, 6, 12, 24 month postoperation treatment.

With this main study, there is a plan to assess not only femur fractures patients, but the investigators would like to have addtional groups of the patients with hip and knee allopasty and knee arthroscopy with slightly different follow-up period: before the oparation, 1 and 12 month after the treatment.

Study Design

Study Type:
Observational
Anticipated Enrollment :
350 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Evaluation of the Lower Limb Function After Femur Fracture's Operation Treatment
Actual Study Start Date :
Sep 1, 2019
Anticipated Primary Completion Date :
Sep 1, 2020
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Femur fracture

Stabilization of femur fracture according to the AO fundation guidelines

Other: surgery
surgical treatment of femur fracture, hip and knee alloplasty, knee arthroscopy

Hip alloplasty

Endoprothesis

Other: surgery
surgical treatment of femur fracture, hip and knee alloplasty, knee arthroscopy

Knee alloplasty

Endoprothesis

Other: surgery
surgical treatment of femur fracture, hip and knee alloplasty, knee arthroscopy

Knee arthroscopy

Resection of the meniscus lesion or anterior cruciatus ligamentum reconstruction

Other: surgery
surgical treatment of femur fracture, hip and knee alloplasty, knee arthroscopy

Outcome Measures

Primary Outcome Measures

  1. Subjective assessment of the lower limb function [12 month]

    Questionnaire, score scale - according to the description in questionnaire, lower score- worse outcome

  2. Objective assessment of the lower limb function [12 month]

    Physical exam

Secondary Outcome Measures

  1. Subjective assessment of the lower limb function [3, 6, 24 months]

    Questionnaire, score scale - according to the description in questionnaire, lower score- worse outcome

  2. Objective assessment of the lower limb function [3, 6, 24 months]

    Physical exam

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed Patient Informed Consent

  • Patients planned for the surgical treatment

Exclusion Criteria: n.a.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jagiellonian University Krakow Poland

Sponsors and Collaborators

  • Jagiellonian University

Investigators

  • Principal Investigator: Marcin Bednarek, Jagiellonian University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marcin Bednarek, Principal Investigator, Jagiellonian University
ClinicalTrials.gov Identifier:
NCT04062604
Other Study ID Numbers:
  • ELLFF1
First Posted:
Aug 20, 2019
Last Update Posted:
Feb 17, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2020